Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...